Edwin Ryan, MD
Ophthalmology · Minneapolis, MNNPI 1093703167
Payments from drug & device makers
Across 54 payments — averaging $177,506 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$9.3M
- Alcon Research LLC$285K
- Dutch Ophthalmic, USA$146
- Astellas Pharma US Inc$46
- Alimera Sciences, Inc.$38
What the payments were for
- Royalty or licence$9,565,083100%
- Consulting fees$14,1120%
- Speaking & faculty fees$3,5000%
- Travel & lodging$1,2810%
- Food & beverage$1,3410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 45 | $9,300,497 |
| Alcon Research LLC | 6 | $284,591 |
| Dutch Ophthalmic, USA | 1 | $146 |
| Astellas Pharma US Inc | 1 | $46 |
| Alimera Sciences, Inc. | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FINESSE SHARKSKIN$3,164
- NGENUITY$599
- Constellation$147
- EVA, combined machine$146
- TISSUEBLUE$146
- Unity$138
How this compares
$9,585,317 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 127 | $6,426 |
| Difluprednate | 14 | $1,798 |
| Ketorolac Tromethamine | 57 | $1,244 |
| Timolol Maleate | 14 | $1,105 |
| Brimonidine Tartrate | 11 | $818 |
| Atropine Sulfate | 12 | $439 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 55 | $432 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 19 | $311 |
| Latanoprost | 23 | $163 |
| Prednisone | 16 | $40 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Minneapolis
- Robert MittraMinneapolis$5.1M
- David ParkeMinneapolis$4.5M
- John DaviesMinneapolis$1.3M
- Sundeep DevMinneapolis$673K
- Raymond AreauxMinneapolis$262K
- David HardtenMinneapolis$149K
- Sherman ReevesMinneapolis$110K
- Sandra MontezumaMinneapolis$83K
- Silvia Orengo-NaniaMinneapolis$12K
- Michael LeeMinneapolis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.